iTeos Therapeutics, Inc.·4

Nov 19, 7:59 PM ET

Gall Matthew 4

4 · iTeos Therapeutics, Inc. · Filed Nov 19, 2024

Insider Transaction Report

Form 4
Period: 2024-11-19
Gall Matthew
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2024-11-19$7.73/sh+5,000$38,63565,429 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4